Clinical Trial Update: Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

A Mayo Clinic-sponsored Phase 2 trial evaluated inhaled sodium nitrite for heart failure with preserved ejection fraction; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Inhaled Sodium Nitrite (sodium nitrite)

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2017-01-19